According to the research report titled ‘Global Lung Cancer Surgery Market Size study, by Surgical Devices (Surgical Instruments, Monitoring & Visualising Systems, Endosurgical Equipment), by Surgical Procedures ( Thoracotomy, Minimally Invasive Surgeries)and Regional Forecasts 2021-2027‘, available with Market Study Report, global lung cancer surgery market was worth USD 5.4 billion in 2020 and is reckoned to record a compound annual growth rate of 3.8 % during 2021-2027 to accumulate USD 7 billion by the end of forecast period.
 

Rising pool of patients ailed by lung cancer, emphasis on early cancer detection and treatment as well as availability of reimbursement policies are catalyzing the growth of global lung cancer surgery market. Notably, increasing consumption of tobacco and habit of smoking are leading causes of lung cancer.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3930302/
 

Moreover, favorable financial environment, technological advancements in the field of cancer treatment, soaring geriatric populace, coupled with emerging economies are propelling the market expansion.
 

Elucidating on the negatives, high cost of lung cancer diagnosis and treatments is restraining the growth of this business domain.
 

In terms of surgical devices, worldwide lung cancer surgery industry is bifurcated into endosurgical equipment, monitoring & visualizing systems, and surgical instruments, whereas speaking of surgical procedures, the market space consists of minimally invasive surgeries, and thoracotomy.
 

The report entails information about the industry share held by aforementioned segments, alongside their growth trend and contribution towards revenue inflow in the coming years.
 

From regional point of view, North America, Latin America, Asia-Pacific, and Europe are key avenues for the market partakers. The document claims that North America held major industry share in the recent past, owing to surging technological innovations in treating lung cancer.
 

Parallelly, Asia Pacific industry is slated to register the highest growth in the ensuing years, owing to rising emphasis of diagnosing and treating cancer. Further, escalating trend of smoking leading to cancer is also aiding the market dynamics.
 

Leading companies in global lung cancer surgery market include AngioDynamics Inc., Intuitive Surgical Inc., Teleflex Incorporated, Siemens Healthineers AG, Accuray Incorporated, Ethicon Inc., Olympus Corporation, Ackermann Instrumente GmbH, Scanlan International Inc., and Richard Wolf GmbH among others.